🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🤔How can I measure non adherence after transplantation ? ✅ think about the immunosupressant Possession Ratio which Captures a Non-Adherence Associated With Antibody-Mediated Rejection frontierspartnerships.org/articles/10.33…

QuPath v0.5.0 is now available! Download it at qupath.github.io See changes at github.com/qupath/qupath/… This is a major update & the culmination of a busy few months for the QuPath team... More below👇 #opensource #bioimageanalysis #digitalpathology #javafx #microscopy

Finally, the Banff 2022 Meeting Report and Workplan manuscripts underwent standard peer review by American Journal of Transplantation, before being accepted and published. Importantly, it was decided that the Banff Meeting Report manuscript(s) are made Gold Open Access.

A nice collaborative work from the French Nephropathology Group!

Our study on post-transplant TMA is out! TMA is mostly driven by AMR and CNI toxicity but often due to multiple factors, with higher rates of complement pathogenic variants, and associated with a poor prognosis.

More on “atypical anti-GBM disease”! Worldwide collaborative by B Chauveau et al published in AJKD doi.org/10.1053/j.ajkd… also see my commentary “Anti–GBM Disease: Broadening the Spectrum” doi.org/10.1053/j.ajkd… #renalpath Renal Pathology Society Mayo Clinic Nephrology Mayo Clinic Pathology

Abstract time for the #Banff2024 allograft pathology meeting 👇🏻👇🏻

⚠️Happy to share our preliminary results on Imlifidase together with the French transplant community. 🙏🏻 Kamar Nassim Dom B Sophie Caillard SFT Transplantation SFT JUNIORS More to come in 2025 🚨 kireports.org/article/S2468-…

Unveiling glomerular gold in oxalate nephropathy - Kidney International kidney-international.org/article/S0085-…

Glad to share our EU-TRAIN Project paper published in Kidney International! 🙌   🙏 to the amazing #consortium behind this #biomarker validation study funded by European Commission Horizon Europe 🇪🇺 🇪🇺   Alexandre Loupy C. Lefaucheur Paris Transplant Group ESOTtransplant TTS   kidney-international.org/article/S0085-…

Dive into the #HORUS_CMV project with hannah kaminski, sharing insights on the team's efforts to understand #CMV's impact on transplant patients. Learn how they’re identifying signatures for personalised care to improve patient outcomes. Watch the full video: horus-project.eu

Kidney-transplant microvascular inflammation has a varied clinical presentation. This study of more than 16,000 biopsy specimens supports the recognition of additional rejection phenotypes to standardize diagnostics. nej.md/4hiFoyJ #KidneyWk

We now have a mass spectrometry test available for membranous nephropathy (MN) antigens. Started in 2017 with no lab/funding (& still no lab/major funding)-one at a time-we were able to discover majority of MN antigens. It was an idea that worked out. news.mayocliniclabs.com/2025/01/21/ass…

Evolving the Banff Classification for Kidney Allograft Rejection. This review paper by Bertrand Chauveau et al. reports that innovations are reshaping rejection diagnostics! #Transplantation #KidneyTransplant #Transplantation #TXPforAll tinyurl.com/zh6m6wh6

🧬Excited to share our new paper in American Journal of Transplantation “Molecular diagnosis of kidney allograft rejection using the B-HOT gene panel” amjtransplant.org/article/S1600-… #MolecularDiagnostics #Transplantation

How many gene transcripts do you actually need to diagnose rejection phenotypes after kidney transplantation? In our latest study in KIReports, we found that the answer is surprisingly low! kireports.org/article/S2468-… 1/6